Opportunity Information: Apply for RFA MH 14 212
Apply for RFA MH 14 212
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (R34)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants.
- This funding opportunity was created on Aug 7, 2013 and posted on Aug 7, 2013.
- Applicants must submit their applications by Jan 6, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $5,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $225,000.00 in funding.
- Eligible applicants include: Special district governments Others (see text field entitled Additional Information on Eligibility for clarification) County governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Private institutions of higher education State governments Small businesses For profit organizations other than small businesses City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal organizations (other than Federally recognized tribal governments).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH funding opportunity RFA-MH-14-212, titled "Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (R34)," is a discretionary grant program focused on strengthening early intervention research for people who are considered clinically high risk for developing psychotic disorders. The central idea behind the announcement is that psychotic disorders can be profoundly disruptive and disabling, and that intervening earlier in the course of risk states may help prevent or delay the onset of psychosis while also reducing other common and damaging outcomes, including mood problems, substance use disorders, and declines in social, school, and work functioning. This R34 mechanism emphasizes early-stage, applied research that can move the field toward practical, stepwise approaches to care in the United States.
The announcement prioritizes projects that develop and pilot-test interventions aimed at the symptoms and functional difficulties seen in clinical high-risk states. In practice, that means proposals are expected to focus on intervention development and feasibility work rather than large definitive efficacy trials. Applicants are encouraged to design and refine strategies that directly address challenges common in high-risk presentations, such as distressing subthreshold psychotic symptoms, anxiety or depression, impaired social functioning, academic or vocational difficulties, and other factors that can set the stage for long-term disability even if full psychosis never emerges.
A second major aim is to support studies that examine how and why these interventions work by investigating mediators and mechanisms of action. Rather than only asking whether an approach helps, the program is looking for research that can clarify which components drive change, what targets are being affected (for example, stress reactivity, cognitive biases, social processes, sleep disruption, or other plausible pathways), and how improvements in those targets translate into better clinical and functional outcomes. This kind of mechanism-focused work is intended to make future intervention efforts more precise and efficient, and to help the field avoid one-size-fits-all models that may not fit real-world clinical settings.
The opportunity is also explicitly designed to build an evidence base that can support stepped care models for early psychosis intervention. A stepped care approach generally means matching people to the least intensive, most appropriate intervention first, then "stepping up" to more intensive services when clinically indicated. The goal is to develop data that can inform what those steps should look like for high-risk states, who should receive which level of care, and when escalation or de-escalation makes sense based on measurable clinical and functional indicators.
Another key emphasis is real-world implementation feasibility, especially in community-based treatment settings. The announcement encourages projects that do not remain confined to specialty academic clinics, but instead consider whether proposed approaches can be delivered in typical service environments with realistic staffing, training, time demands, and resource constraints. This includes attention to practicality, acceptability to patients and providers, and the kinds of workflows and supports that would be needed for community clinics, school-linked services, coordinated specialty care programs, or other accessible points of care.
From an administrative standpoint, this is a mental health research grant under CFDA 93.242, administered by the National Institutes of Health. The program did not require cost sharing or matching funds. The estimated total funding listed for the initiative was $5,000,000, with an award ceiling of $225,000 (as stated in the source data). The announcement was posted on August 7, 2013, with an original and current closing date of January 6, 2014, and an archive date of February 6, 2014, meaning it is no longer open but remains informative as a description of NIH priorities in this area at that time.
Eligibility was broad and included many types of domestic applicants such as state and local governments, public and private institutions of higher education, nonprofits (including both 501(c)(3) and certain non-501(c)(3) entities), independent school districts, public housing authorities/Indian housing authorities, and for-profit organizations (including small businesses and other for-profits). The eligibility language also extended to a range of special categories such as historically Black colleges and universities, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian-serving institutions, and Asian American and Native American Pacific Islander-serving institutions. Importantly, foreign organizations and foreign institutions were also eligible to apply, and non-U.S. components of U.S. organizations could participate, with foreign components allowed under NIH policy definitions.
Overall, this R34 opportunity was structured to push the field toward practical, evidence-informed early intervention for clinical high-risk states by funding pilot and feasibility work, encouraging mechanism-oriented research, and building the groundwork for stepped care approaches that can actually be implemented in community settings where most people receive care.
Frequently Asked Questions (FAQs)
What is the funding opportunity RFA-MH-14-212?
RFA-MH-14-212 is an NIH funding opportunity titled "Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (R34)." It is a discretionary mental health research grant program designed to strengthen early intervention research for individuals considered clinically high risk for developing psychotic disorders.
What is the main purpose of this R34 program?
The program aims to advance early-stage, applied research that can move the field toward practical, stepwise approaches to care in the United States. It prioritizes developing and pilot-testing interventions for clinical high-risk states, understanding how those interventions work (mechanisms/mediators), and building evidence to support stepped care models that can be implemented in real-world settings.
Why does this opportunity focus on people at clinical high risk for psychosis?
The announcement is based on the idea that psychotic disorders can be profoundly disruptive and disabling. By intervening earlier during clinical high-risk states, research may help prevent or delay the onset of psychosis and reduce other damaging outcomes such as mood problems, substance use disorders, and declines in social, school, and work functioning.
What types of projects are prioritized under this announcement?
Projects that develop and pilot-test interventions aimed at the symptoms and functional difficulties seen in clinical high-risk states are prioritized. The emphasis is on intervention development and feasibility work rather than large, definitive efficacy trials.
Does this funding support large-scale efficacy trials?
Based on the description provided, the R34 mechanism emphasizes early-stage applied research, specifically intervention development and feasibility/pilot-testing, rather than large definitive efficacy trials.
What kinds of clinical and functional problems should proposed interventions address?
The opportunity highlights challenges commonly seen in high-risk presentations, including distressing subthreshold psychotic symptoms, anxiety or depression, impaired social functioning, academic or vocational difficulties, and other factors that may contribute to long-term disability even if full psychosis never develops.
What does the opportunity mean by studying mediators and mechanisms of action?
In addition to assessing whether an intervention helps, the program encourages research that examines how and why an intervention works. This includes identifying which components drive change, what targets are affected (for example, stress reactivity, cognitive biases, social processes, sleep disruption, or other plausible pathways), and how changes in those targets relate to clinical and functional improvements.
Why is mechanism-focused research emphasized?
The mechanism focus is intended to make future intervention efforts more precise and efficient and to help the field avoid one-size-fits-all models that may not translate well into real-world clinical settings.
What are stepped care models, and how does this opportunity relate to them?
A stepped care approach generally means starting people with the least intensive, most appropriate intervention and then stepping up to more intensive services when clinically indicated. This opportunity seeks to build evidence that can inform what the steps should be for high-risk states, who should receive which level of care, and when escalation or de-escalation should occur based on measurable clinical and functional indicators.
Does the opportunity encourage research in community-based settings?
Yes. A key emphasis is real-world implementation feasibility, especially in community-based treatment environments. The announcement encourages projects that consider delivery in typical service settings, not only specialty academic clinics.
What kinds of practical implementation factors are expected to be considered?
The description highlights practicality and feasibility in real-world settings, including acceptability to patients and providers, realistic staffing and training needs, time demands, resource constraints, and the workflows and supports needed in community clinics, school-linked services, coordinated specialty care programs, or other accessible points of care.
Which agency administers this opportunity?
This is an NIH-administered mental health research grant program.
What is the CFDA number associated with this program?
The program is listed under CFDA 93.242.
Is cost sharing or matching required?
No. The information provided states that the program did not require cost sharing or matching funds.
How much funding was estimated for this initiative?
The estimated total funding listed for the initiative was $5,000,000.
What was the award ceiling?
The award ceiling is listed as $225,000 (as stated in the source data provided).
When was the opportunity posted?
The announcement was posted on August 7, 2013.
What were the closing date and archive date?
The original and current closing date was January 6, 2014, and the archive date was February 6, 2014.
Is this funding opportunity currently open?
No. Based on the closing and archive dates provided, it is no longer open. However, it remains informative as a description of NIH priorities in this area at that time.
Who was eligible to apply?
Eligibility was broad and included many types of domestic applicants such as state and local governments, public and private institutions of higher education, nonprofits (including 501(c)(3) and certain non-501(c)(3) entities), independent school districts, public housing authorities/Indian housing authorities, and for-profit organizations (including small businesses and other for-profits).
Were specific institution types explicitly included in eligibility?
Yes. The eligibility language extended to historically Black colleges and universities, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian-serving institutions, and Asian American and Native American Pacific Islander-serving institutions.
Were foreign organizations eligible?
Yes. The information provided states that foreign organizations and foreign institutions were eligible to apply. It also notes that non-U.S. components of U.S. organizations could participate, with foreign components allowed under NIH policy definitions.
What is the overall theme or expected impact of this R34 opportunity?
Overall, the opportunity was structured to push the field toward practical, evidence-informed early intervention for clinical high-risk states by funding pilot and feasibility work, encouraging mechanism-oriented research, and laying groundwork for stepped care approaches that can be implemented in community settings where most people receive care.
Browse more opportunities from the same category: Health
Next opportunity: Providence Parks Urban Presence Partnership Project
Previous opportunity: Research to Improve the Care of Persons at Clinical High Risk for Psychotic Disorders (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MH 14 212
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MH 14 212) also looked into and applied for these:
| Funding Opportunity |
|---|
| PPHF 2013 Immunization Increasing Human Papillomavirus (HPV) Vaccination Coverage Rates among Adolescents financed solely by 2013 Prevention and Public Health Funds Apply for CDC RFA IP13 130101PPHF13 Funding Number: CDC RFA IP13 130101PPHF13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Methods for Prevention Packages Program III (MP3 III) (R01) Apply for PAR 13 322 Funding Number: PAR 13 322 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| IIS Sentinel Site Pandemic Preparedness and Response Planning Apply for CDC RFA IP13 130201SUPP13 Funding Number: CDC RFA IP13 130201SUPP13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| 2014 NIH Pioneer Award Program (DP1) Apply for RFA RM 13 006 Funding Number: RFA RM 13 006 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| 2014 NIH Directors New Innovator Award Program (DP2) Apply for RFA RM 13 007 Funding Number: RFA RM 13 007 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Limited Pilot for NIGMS Legacy Community Wide Scientific Resources (R24) Apply for PAR 13 324 Funding Number: PAR 13 324 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03) Apply for RFA AG 14 010 Funding Number: RFA AG 14 010 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| NIA Revision and Resubmission Program Project Applications (P01) Apply for PAR 13 329 Funding Number: PAR 13 329 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Audacious Goals Initiative High Priority Research Area Intersection of Aging and Biological Mechanisms of Eye Disease (R01) Apply for PA 13 332 Funding Number: PA 13 332 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Bridges to Baccalaureate Program (R25) Apply for PAR 13 333 Funding Number: PAR 13 333 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| State and Regional Primary Care Association (PCA) Cooperative Agreements for Alaska, Georgia, and Wyoming Apply for HRSA 14 032 Funding Number: HRSA 14 032 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| National Indian Health Outreach and Education II Apply for HHS 2013 IHS NIHOE 0002 Funding Number: HHS 2013 IHS NIHOE 0002 Agency: Indian Health Service Category: Health Funding Amount: $150,000 |
| NIH Directors Early Independence Awards (DP5) Apply for RFA RM 13 009 Funding Number: RFA RM 13 009 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Onsite Tools and Technologies for Heart, Lung, and Blood Clinical Research Point of Care SBIR (R43/R44) Apply for RFA HL 14 011 Funding Number: RFA HL 14 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Onsite Tools and Technologies for Heart, Lung, and Blood Clinical Research Point of Care STTR (R41/R42) Apply for RFA HL 14 017 Funding Number: RFA HL 14 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (Round Mountain, CA and Cheyenne, WY) Apply for HRSA 14 100 Funding Number: HRSA 14 100 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Smallpox Research Oversight Activities Apply for EP IDS 13 003 Funding Number: EP IDS 13 003 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $290,000 |
| Library of Integrated Network Based Cellular Signatures (LINCS) Perturbation Induced Data and Signature Generation Centers (U54) Apply for RFA RM 13 013 Funding Number: RFA RM 13 013 Agency: National Institutes of Health Category: Health Funding Amount: $1,700,000 |
| State Vital Statistics Improvement Program Apply for CDC RFA SH12 12010203SUPP13 Funding Number: CDC RFA SH12 12010203SUPP13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $110,000 |
| Cooperative Agreement on Occupational Health with the World Health Organization (WHO) Implementing World Health Assembly Resolution 60.26 Global Plan of Action for Workers Health 2008 2017 Apply for RFA OH 14 002 Funding Number: RFA OH 14 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 14 212", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.